Presentation of e-COM 4 CHILDREN training materials in Prague
The first multiplier event of the project was held on 18 June, where the e-COM 4 CHILDREN training materials were presented and the challenges of e-commerce of children's products faced by businesses, consumer organisations and consumer authorities were presented.…
Third meeting of the e-COM 4 CHILDREN project partners on 3 October in Italy.
On 3 October, we met at the Università Pollitecnica delle Marche in Ancona (Italy) to make further progress in the production of training materials on e-commerce of safe children's products and to initiate the development of the interactive comic,…
Training activity at the Università Politecnica delle Marche, Ancona (Italy).
A short joint training activity for staff of the project partners took place from 3 to 6 July 2018. The main objective of this meeting was to exchange knowledge between the partners in order to address the challenges faced…
Walt Disney also uses Big Data
Walt Disney, one of the world’s largest and most highly valued companies according to the prestigious Forbes magazine, has developed a Big Data system for the collection and analysis of visitor activity data at its theme parks, which has so far been implemented at its Orlando park in Florida. Every year 100 million people visit its theme parks using its attractions, buying Disney products, eating in its restaurants and sleeping in its hotels. Thus, the activity of these visitors can result in a large amount of data if properly recorded and stored. Analysis of the immense volume of data generated on a daily basis can provide Disney with solid knowledge for strategic decision making, thus helping to improve its theme parks by making them more productive, accessible and therefore profitable, offering visitors what they need at any given moment.
Big pharma companies bet on BIG DATA partnership
This week, 3 different initiatives have emerged in the pharmaceutical industry to share their information.
- The most ambitious one has been the Data Sphere Project, which was announced a few days ago, where clinical diagnostic data will be shared for cancer research. Right now the number of datasets is small, but there is already a list of companies willing to contribute information, among others, Bayer or Pfizer. The main objective of this project is to accelerate the discovery and development of effective treatments for the disease. A professional researcher profile is required for access, but access to the data is free of charge. The technology used to build the system is SAS, which will host the service and provide analysis.